Cargando…
CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma
The general prognosis of patients with hepatocellular carcinoma (HCC) remains extremely dismal, due to the high frequency of metastasis. Since 2003, our research group has explored the gene expression profiles of metastasized HCC tissue samples and identified a significant upregulation of CCN3. Howe...
Autores principales: | Jia, Qingan, Xue, Tongchun, Zhang, Qiangbo, Cheng, Wei, Zhang, Chun, Ma, Jingwei, Bu, Yang, Yu, Songning, Liu, Qingguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653869/ https://www.ncbi.nlm.nih.gov/pubmed/29061995 http://dx.doi.org/10.1038/s41598-017-14087-4 |
Ejemplares similares
-
Maintenance of stemness is associated with the interation of LRP6 and heparin-binding protein CCN2 autocrined by hepatocellular carcinoma
por: Jia, Qingan, et al.
Publicado: (2017) -
CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?
por: Jia, Qingan, et al.
Publicado: (2015) -
CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma
por: Liao, Xia, et al.
Publicado: (2019) -
Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma
por: Li, Weimin, et al.
Publicado: (2019) -
Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma
por: Liao, Xia, et al.
Publicado: (2019)